Impression Healthcare's Dr Sud Agarwal on obstructive sleep apnoea and cannabinoids

“The cost of obstructive sleep apnoea to the Australian population is $21.2 billion per annum.”

Dr Sud Agarwal presented at Impression Healthcare’s (ASX: IHL) annual general meeting on Friday 4th October 2019.

For the full video visit:
https://www.youtube.com/watch?v=cChYzDncNz4

———————–

Small Caps is Australia’s #1 site for market news & information on ASX listed small cap companies.

———————–
WEBSITE
https://smallcaps.com.au/

SOCIAL MEDIA
Facebook: https://www.facebook.com/SmallCapsASX
Twitter: https://twitter.com/SmallCapsASX
LinkedIn: https://www.linkedin.com/company/small-caps/

NEWSLETTER
https://smallcaps.com.au/subscribe/

source